scispace - formally typeset
M

Maria A. Aronova

Researcher at National Institutes of Health

Publications -  80
Citations -  3211

Maria A. Aronova is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Electron tomography & Platelet. The author has an hindex of 23, co-authored 73 publications receiving 2640 citations.

Papers
More filters
Journal ArticleDOI

Biodegradable Gold Nanovesicles with an Ultrastrong Plasmonic Coupling Effect for Photoacoustic Imaging and Photothermal Therapy

TL;DR: A novel theranostic platform based on biodegradable plasmonic gold nanovesicles for photoacoustic (PA) imaging and PTT with improved clearance of the dissociated particles after the completion of PTT is reported.
Journal ArticleDOI

Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast

TL;DR: Iron is distributed over laminae in a pattern that is suggestive of each region’s myeloarchitecture and forms the dominant source of the observed MRI contrast.
Journal ArticleDOI

Self-Assembly of Amphiphilic Plasmonic Micelle-Like Nanoparticles in Selective Solvents

TL;DR: The self-assembly, modeling, and applications of APMN assemblies in selective solvents resulted in strong absorption in near-infrared range due to the remarkable plasmonic coupling of Au cores, thus facilitating their biomedical applications in bioimaging and photothermal therapy of cancer.
Journal ArticleDOI

Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

TL;DR: Effective transvascular drug delivery into malignant glioma cells can be accomplished by using nanoparticles that are smaller than 11.7 to 11.9 nm in diameter, which is the therapeutically relevant upper limit of blood-brain tumor barrier pore size.
Journal ArticleDOI

Chimeric ferritin nanocages for multiple function loading and multimodal imaging.

TL;DR: A good tumor targeting profile was observed, which was attributable to both the enhanced permeability and retention (EPR) effect and biovector mediated targeting, which promises ferritin particles as a powerful nanoplatfom in the era of nanomedicine.